Liraglutide’s monthly cost depends on the version prescribed, dose, insurance coverage, pharmacy pricing, and whether a generic or compounded option is used. Brand-name Saxenda and Victoza can be costly without insurance, while coverage is often stronger for type 2 diabetes than for weight loss. Chia does not currently offer liraglutide, but we do offer clinician-reviewed GLP-1 alternatives.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How much does liraglutide cost per month?
Liraglutide can cost very different amounts month to month because the final price depends on insurance, dose, diagnosis, pharmacy, and whether the prescription is for a brand or generic product. There is no single national cash price that applies to every patient, so the most useful estimate is the price your insurer and pharmacy quote for your exact prescription.
Quick facts: liraglutide monthly cost factors
- Brand: Victoza and Saxenda are both liraglutide products, but they are labeled for different uses.
- Diagnosis: type 2 diabetes coverage may differ from chronic weight management coverage.
- Dose and quantity: higher-dose weight-management use may require more medication each month.
- Insurance rules: prior authorization, step therapy, and formulary tier can change your out-of-pocket cost.
- Pharmacy pricing: cash prices and discount-card prices can vary by pharmacy and location.
Why the price can differ by dose, indication, and pharmacy
Liraglutide is given as a subcutaneous injection and has pharmacokinetics that support once-daily use 1. The FDA-approved liraglutide products use different labeled dose ranges for diabetes and weight management, so the number of pens needed in a month can differ 2, 3.
Why weight-management dosing may cost more than diabetes dosing
Saxenda’s FDA label describes liraglutide 3 mg once daily for chronic weight management, while Victoza’s label for type 2 diabetes uses lower daily maintenance doses 2, 3. That label difference is one reason weight-management fills may involve more medication per month. Side effects and contraindications still matter at any dose, especially nausea, vomiting, gallbladder disease risk, pancreatitis warnings, and boxed-warning topics from the label 2, 3.
| Cost factor | Why it matters | What to verify |
|---|---|---|
| Brand vs generic | Generic liraglutide may price differently than Saxenda or Victoza. | Ask whether the prescription can be filled as generic liraglutide. |
| Diagnosis | Plans often treat diabetes and weight-loss coverage differently. | Ask if the drug is covered for your diagnosis code. |
| Dose and quantity | The monthly amount dispensed can change the cost. | Ask how many pens or units are included in the monthly fill. |
| Insurance rules | Prior authorization or step therapy may be required. | Ask what documents are needed before filling. |
| Pharmacy | Retail cash prices vary. | Compare the same prescription at more than one pharmacy. |
What is liraglutide, and what is it prescribed for?
Liraglutide is a GLP-1 receptor agonist, also called an incretin mimetic. It is used in FDA-approved products for type 2 diabetes, cardiovascular risk reduction in certain adults with type 2 diabetes, and chronic weight management in adults and certain adolescents who meet label criteria 1, 2, 3.
Liraglutide as a GLP-1 receptor agonist
GLP-1 receptor agonists mimic a gut hormone involved in blood sugar and appetite signaling. Liraglutide binds GLP-1 receptors, increases glucose-dependent insulin secretion, suppresses glucagon when glucose is elevated, slows gastric emptying, and acts on appetite-regulation pathways 1. These same mechanisms can also cause gastrointestinal side effects, such as nausea, vomiting, diarrhea, and constipation 2, 3.
Victoza for type 2 diabetes and cardiovascular risk reduction
Victoza is the brand-name liraglutide product labeled for improving glycemic control in adults and children 10 years and older with type 2 diabetes, along with diet and exercise 2. It is also labeled to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease 2. In the LEADER trial, liraglutide was studied in 9,340 patients with type 2 diabetes and high cardiovascular risk; benefits must be weighed against risks and individual results vary 5.
Saxenda for chronic weight management
Saxenda is the brand-name liraglutide product labeled for chronic weight management with a reduced-calorie diet and increased physical activity in adults with obesity, adults who are overweight with at least one weight-related condition, and certain adolescents who meet label criteria 3. In the SCALE Obesity and Prediabetes trial, liraglutide 3.0 mg was studied for weight management over 56 weeks, but results vary and treatment requires clinician supervision 4.
Generic liraglutide and what it does and does not replace
Generic liraglutide refers to an FDA-approved generic version of a liraglutide product, depending on the specific approval and labeling. It does not automatically replace every liraglutide brand for every use, and a prescriber or pharmacist must confirm whether substitution is appropriate for the product, indication, and state law.
Is liraglutide covered by insurance?
Insurance coverage for liraglutide often depends on why it is prescribed. A plan may cover a GLP-1 medication for type 2 diabetes but use different rules, or no coverage, for chronic weight management.
Why coverage often depends on diabetes vs weight-loss use
Victoza and Saxenda have different FDA-labeled indications, so insurers may place them in different coverage categories 2, 3. Coverage decisions can also depend on body mass index, HbA1c, weight-related comorbidities, prior medication history, and whether the plan covers anti-obesity medications.
Prior authorization, step therapy, and formulary tiers
A prior authorization means your clinician may need to submit medical information before the plan pays. Step therapy means the plan may ask you to try another covered option first. A formulary tier affects your copay or coinsurance.
What to ask Blue Cross Blue Shield or any insurer before filling a prescription
- Is liraglutide covered for my diagnosis?
- Is the covered product Victoza, Saxenda, generic liraglutide, or another GLP-1?
- Does the plan require prior authorization?
- Does the plan require step therapy?
- What is my estimated monthly out-of-pocket cost at my preferred pharmacy?
- Is there a mail-order option, and does it change the price?
Can my doctor prescribe liraglutide?
A licensed clinician can prescribe liraglutide when it is clinically appropriate and legally permitted. The decision depends on the patient’s diagnosis, medical history, medication list, contraindications, and treatment goals.
Who may be eligible based on approved indications
For weight management, liraglutide is labeled for adults with a body mass index of 30 or higher, or 27 or higher with at least one weight-related comorbidity, plus certain adolescents who meet label criteria 3. For type 2 diabetes, liraglutide is labeled as an adjunct to diet and exercise to improve glycemic control in adults and children 10 years and older 2.
Why a clinician review is required
GLP-1 medications affect glucose, appetite, gastric emptying, and digestion 1. A clinician review helps check whether the expected benefit is reasonable and whether risks, interactions, pregnancy status, gallbladder history, pancreatitis history, or other safety factors need attention 2, 3.
Safety history and medication review before prescribing
The official labels for liraglutide products include warnings about thyroid C-cell tumors in rodents, pancreatitis, gallbladder disease, hypoglycemia risk when used with insulin or insulin secretagogues, kidney injury related to dehydration, heart-rate increase, and hypersensitivity reactions 2, 3. That is why dosing and monitoring should be guided by a clinician, not copied from an online post.
Is liraglutide worth it compared with other GLP-1 medications?
Value depends on cost, coverage, evidence, tolerability, and convenience. Liraglutide has strong human data and long clinical use, but newer GLP-1 and GIP/GLP-1 medications may be more convenient because many are taken once weekly rather than once daily.
How cost, evidence, tolerability, and convenience affect value
In diabetes, liraglutide has human outcomes data, including cardiovascular outcomes in the LEADER trial 5. In weight management, liraglutide 3.0 mg has randomized-trial evidence, but gastrointestinal side effects were common and individual results varied 4.
Liraglutide vs semaglutide
Semaglutide is another GLP-1 receptor agonist; Ozempic is labeled for type 2 diabetes, and Wegovy is labeled for chronic weight management and certain cardiovascular-risk uses 6, 7. In the STEP 1 trial, semaglutide 2.4 mg once weekly was studied for weight management, but those results apply to the studied FDA-approved product and do not establish outcomes for compounded formulations 8. Semaglutide can also cause nausea, vomiting, diarrhea, constipation, gallbladder events, pancreatitis warnings, and other label-listed risks 6, 7.
Liraglutide vs tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist; Mounjaro is labeled for type 2 diabetes, and Zepbound is labeled for chronic weight management and certain obstructive sleep apnea uses 9, 10. In the SURMOUNT-1 trial, tirzepatide was studied as a once-weekly injection for adults with obesity or overweight without diabetes; individual results varied and gastrointestinal side effects were common 11.
Daily injection vs weekly injection considerations
| Option | Drug class | Typical schedule in FDA labeling | Main practical trade-off |
|---|---|---|---|
| Liraglutide | GLP-1 receptor agonist | Once daily | More frequent injections; long clinical history |
| Semaglutide | GLP-1 receptor agonist | Once weekly for Ozempic and Wegovy | Less frequent injections; coverage and supply vary |
| Tirzepatide | Dual GIP/GLP-1 receptor agonist | Once weekly for Mounjaro and Zepbound | Less frequent injections; different mechanism |
What lower-cost options may be available?
Lower-cost options may include generic liraglutide, insurance appeals, savings programs, pharmacy shopping, or a clinician-reviewed compounded medication when appropriate and legally available. Chia does not currently offer compounded liraglutide.
Generic liraglutide
Generic availability can lower some medication costs, but the exact patient price depends on the product, pharmacy, insurance plan, and substitution rules. A pharmacist can tell you whether your prescription can be filled with generic liraglutide and what that would cost.
Insurance appeals and savings programs
If coverage is denied, your clinician may be able to submit an appeal with documentation that matches the plan’s policy. Savings programs may help some commercially insured patients, but eligibility rules can change and often exclude government insurance.
Compounded liraglutide via a 503A pharmacy: what patients should know
A 503A compounding pharmacy prepares patient-specific medications pursuant to a prescription and state pharmacy rules. Compounded liraglutide may be discussed in some settings, but Chia does not currently offer liraglutide in any form.
Why compounded medications are not FDA-approved
Compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality 12. The safety axis patients should focus on is licensed care: evaluation by a licensed clinician and dispensing by a state-licensed 503A pharmacy, not no-prescription “research chemical” sellers.
3-min quiz
Considering GLP-1 treatment?
Chia does not currently offer liraglutide. We do offer compounded semaglutide injection and compounded tirzepatide tablets or injection through state-licensed 503A pharmacies when a licensed provider decides treatment is appropriate. A prescription requires medical evaluation and is not guaranteed. Compounded medications are not FDA-approved.
GLP-1 treatment access at Chia: semaglutide and tirzepatide options
At Chia, treatment is 100% online: you complete a health questionnaire, then one of our licensed US providers reviews your history and prescribes only when clinically appropriate. We do not currently offer liraglutide, Victoza, Saxenda, or compounded liraglutide.
Compounded semaglutide injection at Chia
Chia offers compounded semaglutide injection, with plans currently starting at $249/mo. Semaglutide is the active ingredient studied in FDA-approved products such as Ozempic and Wegovy, but compounded semaglutide is not the same as those brand-name products and has not been FDA-reviewed for outcomes 6, 7, 12.
Compounded tirzepatide tablets or injection at Chia
Chia offers compounded tirzepatide tablets or injection. Plans currently start at $249/mo for tablets and $299/mo for injection. Tirzepatide is the active ingredient studied in FDA-approved products such as Mounjaro and Zepbound, but compounded tirzepatide is not those brand-name products and has not been FDA-reviewed for outcomes 9, 10, 12.
| Chia option | Forms | Current starting price | Notes |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | Microdosing plans available when clinically appropriate; compounded medications and nonstandard dosing plans are not FDA-approved |
| Tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | Microdosing plans available when clinically appropriate; compounded medications and nonstandard dosing plans are not FDA-approved |
| Weight + Energy | NAD+ injection + choice of GLP-1 | From $309/mo | Protocol option for patients whose provider finds it appropriate |
| Weight + Muscle | Sermorelin injection + choice of GLP-1 | From $329/mo | Protocol option for patients whose provider finds it appropriate |
Microdosing plans for semaglutide and tirzepatide when clinically appropriate
Chia offers provider-guided microdosing plans for semaglutide and tirzepatide when clinically appropriate. We do not give one-size-fits-all dosing instructions; your provider reviews your goals, medical history, side effects, and response over time. Compounded medications and nonstandard dosing plans are not FDA-approved.
How Chia’s online clinician review, 503A pharmacy fulfillment, and patient portal work
If prescribed, medication is compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Patients can message the care team through the patient portal between visits. Some patients also consider Chia protocols such as Weight + Energy or Weight + Muscle, depending on clinician review; compounded medications are not FDA-approved.
When to take the eligibility quiz
The eligibility quiz is the first step if you want a licensed Chia provider to review whether a Chia-offered GLP-1 option may fit your health history and goals. It is not an approval, and a prescription is never guaranteed.
What safety issues should patients understand before choosing liraglutide or another GLP-1?
GLP-1 safety starts with a real medical review. Liraglutide, semaglutide, and tirzepatide can help some patients, but they also have side effects, contraindications, and monitoring needs.
Common gastrointestinal side effects
Nausea, vomiting, diarrhea, constipation, and abdominal discomfort are common with GLP-1 therapy 2, 3, 7, 10. These effects can affect hydration, nutrition, and whether a patient can stay on therapy.
Contraindications and boxed-warning topics to verify from the official label
Liraglutide labels include a boxed warning about thyroid C-cell tumors in rodents and list contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 2, 3. Similar boxed-warning topics appear on semaglutide and tirzepatide labels 7, 10.
Why dosing should be clinician-guided
FDA labels describe dose-escalation schedules for approved products, but those schedules are not instructions for any individual reader 2, 3, 7, 10. Your clinician should decide whether to start, pause, change, or stop a GLP-1 based on your medical history and side effects.
When to seek medical advice
Patients should contact a clinician promptly for severe abdominal pain, persistent vomiting, signs of dehydration, allergic symptoms, symptoms of low blood sugar if using insulin or sulfonylureas, or any new neck mass or trouble swallowing 2, 3. Emergency symptoms should be treated as urgent.
Frequently asked questions
They are different GLP-1 receptor agonists with different dosing schedules and trial results. Semaglutide weight-management studies generally show larger average weight changes than liraglutide studies, but the right choice depends on coverage, tolerability, safety history, and clinician review 4, 8. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
It can be, especially if generic liraglutide is covered or priced lower at your pharmacy. But monthly cost varies by insurance plan, diagnosis, dose, and pharmacy, so you need a real quote for your prescription.
Not automatically. Generic liraglutide depends on the specific FDA-approved product and labeling. Your prescriber or pharmacist should confirm whether a generic can be substituted for the product and use you were prescribed.
Some plans may cover liraglutide, but coverage varies by state, employer plan, diagnosis, formulary, and prior authorization rules. Ask your plan whether Victoza, Saxenda, or generic liraglutide is covered for your diagnosis.
A licensed telehealth clinician may prescribe liraglutide if it is clinically appropriate and allowed under applicable law. Chia does not currently offer liraglutide.
No. Chia does not currently offer liraglutide, Victoza, Saxenda, generic liraglutide, or compounded liraglutide.
Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection when clinically appropriate after a licensed-provider review. Microdosing plans are available for semaglutide and tirzepatide when appropriate. A prescription is not guaranteed, and compounded medications and nonstandard dosing plans are not FDA-approved.
3-min quiz
Start with a clinician-reviewed GLP-1 visit
If you are comparing GLP-1 options, Chia can review eligibility for semaglutide injection, tirzepatide tablets or injection, or Chia GLP-1 protocols. Chia does not offer liraglutide. A licensed provider must review your history before any prescription, and prescribing is not guaranteed. Compounded medications are not FDA-approved.
References
- 1.Qureshi Z, Twose C, Peddu V, et al. Liraglutide. StatPearls. 2026.
- 2.Novo Nordisk. Victoza (liraglutide) injection prescribing information. U.S. Food and Drug Administration. 2024.
- 3.Novo Nordisk. Saxenda (liraglutide) injection prescribing information. U.S. Food and Drug Administration. 2023.
- 4.Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine. 2015.
- 5.Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine. 2016.
- 6.Novo Nordisk. Ozempic (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 7.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 8.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- 9.Eli Lilly and Company. Mounjaro (tirzepatide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 10.Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 11.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- 12.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
